A prospective study that evaluated the annual cost related to Friedreich’s Ataxia, a neuromuscular disorder due to a genetic mutation in the mitochondrial protein frataxin, showed that hospitalizations contributed to 21% of total direct medical costs in the UK [20], which is consistent with our finding. The gene discussed is FXN; the disease is Friedreich ataxia.